Nath Bio-Genes (India) Ltd

Nath Bio-Genes (India), a microcap in the agri-seeds sector, has reached a new 52-week low, continuing a downward trend with a 7.66% decline over four days. The stock is underperforming against key moving averages and has dropped 22.49% over the past year, contrasting with the Sensex's gains.

Nath Bio-Genes (India), a microcap in the agri-seeds sector, has reached a new 52-week low, continuing a downward trend with a 7.66% decline over four days. The stock is underperforming against key moving averages and has dropped 22.49% over the past year, contrasting with the Sensex's gains.

Nath Bio-Genes (India), a microcap in the agri-seeds sector, has reached a new 52-week low, reflecting a significant decline over the past three days. The stock is trading below multiple moving averages, indicating a bearish trend, while the sector itself has also faced challenges in recent times.

Nath Bio-Genes (India) has announced its financial results for Q3 FY24-25, highlighting a mixed performance. While Profit Before Tax increased to Rs 3.31 crore and net sales for the half-year reached Rs 69.06 crore, Profit After Tax declined to Rs 2.65 crore amid rising interest expenses.

Nath Bio-Genes (India), a microcap company in the agri-seeds industry, reported a negative performance for the quarter ending September 2024, with a 'Sell' call from MarketsMOJO. While the company's operating cash flow and net sales have shown growth, there are concerning factors such as a decline in profit and increased interest costs. Investors should carefully evaluate before investing.

Nath Bio-Genes (India), a microcap company in the agri-seeds industry, has been downgraded to a 'Sell' by MarketsMOJO due to weak long-term fundamentals and underperformance in the market. Despite positive results in the last six quarters, the stock's technical trend is sideways and it is trading at a discount compared to its historical valuations. Majority of shareholders are non-institutional investors.

Nath Bio-Genes has reported a decrease in net profit margin from 17.33% to 16.32% in the last quarter, due to higher expenses. Additionally, the company's debt to equity ratio has increased from 0.00 to 0.01, which could impact its financial stability. While the company has shown positive growth in other areas, investors should monitor its financials and debt levels closely.

Nath Bio-Genes (India) has hit a 52-week high on July 8th, 2024, with a 3.58% gain and outperforming the sector by 1.74%. The stock is currently trading above its moving averages, indicating a bullish trend. In the past year, it has shown a growth of 17.79%, showcasing its consistent performance in the agri-seeds industry.

Nath Bio-Genes (India) has seen a surge in its stock price, reaching a 52-week high of Rs 254.9 on July 4th, 2024. According to MarketsMOJO, the stock call is 'Hold', indicating its expected maintenance of current performance. The stock has outperformed the sector by 2.33% and is trading higher than its moving averages, showing a positive trend. With a growth of 35.32% in the past year, the company's strong performance in the agri-seeds industry makes it a promising player in the microcap market.

Nath Bio-Genes (India), a leading agri-seed company, has seen a surge in its stock price, hitting a 52-week high of Rs. 254.9 on July 3rd, 2024. The stock has gained 20.15% in the past three days and is currently trading higher than its moving averages. With a 1-year performance of 35.07%, the company showcases potential for growth and outperforms the market.

Nath Bio-Genes (India) Ltd, a leading agri-seeds company, reached a 52-week high of Rs.253.85 on July 2nd, 2024. It has consistently outperformed the Sensex and is expected to perform steadily in the near future, according to MarketsMOJO. The stock has been trading above its moving averages, indicating a strong upward trend.

Nath Bio-Genes (India) Ltd, a leading agri-seeds company, has seen a surge in its stock price, reaching a 52-week high of Rs. 249.5 on July 1st, 2024. The stock has outperformed the sector by 15.29% and has consistently traded higher than its moving averages. With a strong performance in the past year, the company remains a promising player in the market.

Nath Bio-Genes (India), a microcap company in the agri-seeds industry, has reported a positive performance in its financial results for the quarter ending March 2024. The company's Profit After Tax (PAT) has increased by 80.7% year on year, while its Operating Profit (PBDIT) has decreased. MarketsMOJO has given a 'Sell' call for the company's stock. Investors should carefully analyze all financial information before making any investment decisions.

Nath Bio-Genes (India), a microcap company in the agri-seeds industry, has been downgraded to a 'Sell' by MarketsMOJO due to weak long-term fundamentals and underperformance in the market. Despite positive results in the last 4 quarters, the stock has a bearish outlook and is currently trading at a discount compared to its historical valuations. Majority of shareholders are non-institutional investors.

Nath Bio-Genes (India), a microcap company in the agri-seeds industry, has been upgraded to a 'Hold' rating by MarketsMOJO due to positive results in the last four quarters. The stock has shown improvement in technical trends and has a potential undervalued stock with a PEG ratio of 0. However, weak long-term fundamentals and underperformance in the market may warrant a 'Hold' rating for now.

Nath Bio-Genes (India), a microcap company in the agri-seeds industry, has been downgraded to 'Sell' by MarketsMOJO due to weak long-term fundamentals and underperformance in the market. The company has shown poor growth and a sideways trend, but has declared positive results in the past year. However, caution is advised for potential investors.

Nath Bio-Genes (India) is a microcap company in the agri-seeds industry. MarketsMOJO recently downgraded their stock call to 'Hold' due to the company's positive results in the last four quarters, with a growth of 183.7% in PAT(Q) and 25.45% in NET SALES(Q). The stock is currently in a bullish range and has attractive valuation and returns, but its long-term fundamental strength is weak.

Nath Bio-Genes (India) is a microcap company in the agri-seeds industry that has recently received a 'Buy' recommendation from MarketsMOJO. With a strong ability to service debt, positive financial results, and attractive valuation, the stock has shown promising growth and a bullish trend. However, concerns about management efficiency and long-term growth should also be considered before investing.

Nath Bio-Genes (India), a microcap company in the agri-seeds industry, has reported a decline in net sales and net profit for the quarter ended September 2023. However, the company's operating profit and interest expenses have shown positive trends. Its strong operating cash flow and higher dividends to shareholders indicate a positive financial performance.